Details werden geladen...
CytomX Therapeutics Announces Q2 2026 Financial Results and Provides Business Update | The Manila Times
Varsetatug masetecan ('Varseta-M”) Program:
Ähnliche Seiten
Vivoryon Therapeutics N.V. Reports H1 2026 Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/08/06/tmt-newswire/globenewswire/vivoryon-therapeutics-nv-reports-h1-2026-financial-results-and-provides-business-update/2399645
Rakovina Therapeutics Announces Q1 2026 Financial Results and Provides Corporate Update | The Manila Times
https://www.manilatimes.net/2026/06/02/tmt-newswire/globenewswire/rakovina-therapeutics-announces-q1-2026-financial-results-and-provides-corporate-update/2356285Vivoryon Therapeutics N.V. Reports Q1 2026 Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/06/11/tmt-newswire/globenewswire/vivoryon-therapeutics-nv-reports-q1-2026-financial-results-and-provides-business-update/2363280Kymera Therapeutics Announces Second Quarter 2026 Financial Results and Provides a Business Update | The Manila Times
https://www.manilatimes.net/2026/08/05/tmt-newswire/globenewswire/kymera-therapeutics-announces-second-quarter-2026-financial-results-and-provides-a-business-update/2398826Gyre Therapeutics Reports Second Quarter 2026 and Year-to-Date Financial Results and Provides Business Update | The Manila Times
https://www.manilatimes.net/2026/08/07/tmt-newswire/globenewswire/gyre-therapeutics-reports-second-quarter-2026-and-year-to-date-financial-results-and-provides-business-update/2400915